Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi High Technologies America, ZS Genetics to Develop EM-Based Sequencing Platform

NEW YORK (GenomeWeb) – ZS Genetics and Hitachi High Technologies America are collaborating to develop and commercialize ZS Genetics' DNA sequencing platform, the companies said today.

ZS Genetics has been working on an electron microscopy-based method to sequence long stretches of DNA that relies on labeling DNA bases with heavy atoms. Under the terms of the strategic collaboration, the companies will combine ZS Genetics' proprietary technologies with HTA's experience in high-resolution EM.

Later this year, ZS Genetics plans to start working with select customers and supply chain partners to develop products and applications at its facility in Wakefield, Massachusetts.

"The technical capabilities of our two companies are expected to produce a DNA sequencing platform capable of enabling unique scientific discovery, as well as offering a powerful tool to complement and broaden current short-read sequencing technologies," said ZS Genetics CEO John McCarthy Jr. in a statement.

The firms did not disclose any additional details or terms about their strategic product development partnership.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.